A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Investigational Drug Gaining Traction Online
The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” images, injection guides and claims of next-day UK delivery. Sellers market the drug there before redirecting customers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Voice Concerns
However, doctors and pharmacists have warned that the distribution of what is still an unapproved drug in the United Kingdom is worrisome and could lead to users administering products of uncertain source.
Some experts stated the popularity for the experimental drug could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for human use under the British medical regulations.
Several content creators try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or imprisonment.
Service Reaction and Material Elimination
Based on TikTok, the platform has removed problematic content and prohibited associated hashtags and query recommendations. The organization said it was committed to keeping the service safe and investing in enhancing compliance measures.
Digital Marketplace Operations
Investigations also discovered communities with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly brings up groups with numerous of members, populated with images of weight loss, glowing testimonials and detailed guides for preparing or administering at residence.
Within minutes of joining one community, a seller shared WhatsApp details, where most purchases take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or previous experience.
Product Details and Costs
Inside these groups, messages display dark colored parcels with Royal Mail labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Service Moderation and Security Measures
A representative for the messaging service stated it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they can’t verify. Although the science behind this drug is valid, these digital versions may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her staff has previously encountered patients injured by personal administration from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to potentially significant health risks”.
